Luke Nathaniel Walker - 04 Sep 2024 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
04 Sep 2024
Net transactions value
$0
Form type
4
Filing time
05 Sep 2024, 08:04:53 UTC
Previous filing
29 May 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +19,315 $0.000000 19,315 04 Sep 2024 Common Stock 19,315 $2.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.